Therapeutic Areas Main Article

Therapeutic Areas

Daiichi Sankyo, Inc. accepts requests for CME and Non-CME programs in the following therapeutic areas:

  • Fibromyalgia
  • Oncology (hepatocellular carcinoma, acute myeloid leukemia, and tenosynovial giant cell tumors)
  • Pain and Opioid-Induced Nausea and Vomiting
  • Thrombosis (atrial fibrillation and venous thromboembolism with respect to the use of non-vitamin K antagonist oral anticoagulants [NOACs])

​​*DSI has expended its available CME budget. Check back for future updates.

Daiichi Sankyo, Inc. is aware of the growing need for support. Many more requests are received than can be funded, and we regret that we cannot accommodate every request. Every request receives a fair review, but in return we ask that you evaluate whether your request fits within our guidelines for submission.

Daiichi Sankyo, Inc. reserves the right to modify, revise or delete therapeutic areas of interest at any time without notice.

DSNA16102802 09/16

Non-Continuing Medical Education Grants Main Article More Stories

More Stories

Daiichi Sankyo Cancer Enterprise

Daiichi Sankyo is focused on aligning rigorous science with unique patients' needs to accelerate the development of innovative therapies for cancer.

read more ...